Critical Care of the Hematopoietic Stem Cell Transplant Recipient

Critical Care Clinics

Volumn 26, Issue 1, 2010, Pages 133-150

  Afessa, Bekele ^a   Azoulay, Elie ^b  

^a Mayo Clinic   (United States)

^b SAINT LOUIS HOSPITAL   (France)

Author keywords

Bone marrow transplantation; Intensive care units; Mechanical ventilation; Mortality; Multiple organ failure; Prognosis

Indexed keywords

COLONY STIMULATING FACTOR; CORTICOSTEROID; DROTRECOGIN; FLUDROCORTISONE; HYDROCORTISONE; HYPERTENSIVE FACTOR;

ACUTE KIDNEY FAILURE; ARTERY CATHETERIZATION; ARTIFICIAL VENTILATION; BLEEDING; BRAIN HEMORRHAGE; BRONCHOSCOPY; CLINICAL TRIAL; GRANULOCYTE TRANSFUSION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INCIDENCE; INTENSIVE CARE; INTENSIVE CARE UNIT; LEUKEMIA; LOW DRUG DOSE; LUNG INFILTRATE; MORTALITY; MULTIPLE MYELOMA; MULTIPLE ORGAN FAILURE; NEUTROPENIA; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; PROGNOSIS; RECIPIENT; RESPIRATORY FAILURE; REVIEW; RISK ASSESSMENT; SEPSIS; SEPTIC SHOCK;

ADULT; CRITICAL CARE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INTENSIVE CARE UNITS;

EID: 70449837098     PISSN: 07490704     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccc.2009.09.001     Document Type: Review

References (87)

1. Pasquini M.C., Wang Z., and Schneider L. Current use and outcome of hematopoietic stem cell transplantation: part I - CIBMTR Summary Slides. Available at:. http://www.cibmtr.org/PUBLICATIONS/Newsletter/DOCS/2007Dec.pdf Accessed June 11, 2009
2. Matulis M., and High K.P. Immune reconstitution after hematopoietic stem-cell transplantation and its influence on respiratory infections. Semin Respir Infect 17 2 (2002) 130-139
3. Ninin E., Milpied N., Moreau P., et al. Longitudinal study of bacterial, viral, and fungal infections in adult recipients of bone marrow transplants. Clin Infect Dis 33 1 (2001) 41-47
4. McArdle J.R. Critical care outcomes in the hematologic transplant recipient. Clin Chest Med 30 1 (2009) 155-167
5. Afessa B., Tefferi A., Hoagland H.C., et al. Outcome of recipients of bone marrow transplants who require intensive- care unit support. Mayo Clin Proc 67 2 (1992) 117-122
6. DeNardo S.J., Oye R.K., and Bellamy P.E. Efficacy of intensive care for bone marrow transplant patients with respiratory failure. Crit Care Med 17 1 (1989) 4-6
7. Jackson S.R., Tweeddale M.G., Barnett M.J., et al. Admission of bone marrow transplant recipients to the intensive care unit: outcome, survival and prognostic factors. Bone Marrow Transplant 21 7 (1998) 697-704
8. Kew A.K., Couban S., Patrick W., et al. Outcome of hematopoietic stem cell transplant recipients admitted to the intensive care unit. Biol Blood Marrow Transplant 12 3 (2006) 301-305
9. Kim D.H., Kim J.G., Lee N.Y., et al. Risk factors for late cytomegalovirus infection after allogeneic stem cell transplantation using HLA-matched sibling donor: donor lymphocyte infusion and previous history of early CMV infection. Bone Marrow Transplant 34 1 (2004) 21-27
10. Letourneau I., Dorval M., Belanger R., et al. Acute renal failure in bone marrow transplant patients admitted to the intensive care unit. Nephron 90 4 (2002) 408-412
11. Naeem N., Eyzaguirre A., Kern J.A., et al. Outcome of adult umbilical cord blood transplant patients admitted to a medical intensive care unit. Bone Marrow Transplant 38 11 (2006) 733-738
12. Paz H.L., Crilley P., Weinar M., et al. Outcome of patients requiring medical ICU admission following bone marrow transplantation. Chest 104 2 (1993) 527-531
13. Scales D.C., Thiruchelvam D., Kiss A., et al. Intensive care outcomes in bone marrow transplant recipients: a population-based cohort analysis. Crit Care 12 3 (2008) R77
14. Torrecilla C., Cortes J.L., Chamorro C., et al. Prognostic assessment of the acute complications of bone marrow transplantation requiring intensive therapy. Intensive Care Med 14 4 (1988) 393-398
15. Trinkaus M.A., Lapinsky S.E., Crump M., et al. Predictors of mortality in patients undergoing autologous hematopoietic cell transplantation admitted to the intensive care unit. Bone Marrow Transplant 43 5 (2009) 411-415
16. Paz H.L., Garland A., Weinar M., et al. Effect of clinical outcomes data on intensive care unit utilization by bone marrow transplant patients. Crit Care Med 26 1 (1998) 66-70
17. Pene F., Aubron C., Azoulay E., et al. Outcome of critically ill allogeneic hematopoietic stem-cell transplantation recipients: a reappraisal of indications for organ failure supports. J Clin Oncol 24 4 (2006) 643-649
18. Soubani A.O., Kseibi E., Bander J.J., et al. Outcome and prognostic factors of hematopoietic stem cell transplantation recipients admitted to a medical ICU. Chest 126 5 (2004) 1604-1611
19. Afessa B., Tefferi A., Dunn W.F., et al. Intensive care unit support and Acute Physiology and Chronic Health Evaluation III performance in hematopoietic stem cell transplant recipients. Crit Care Med 31 6 (2003) 1715-1721
20. Naeem N., Reed M.D., Creger R.J., et al. Transfer of the hematopoietic stem cell transplant patient to the intensive care unit: does it really matter?. Bone Marrow Transplant 37 2 (2006) 119-133
21. Price K.J., Thall P.F., Kish S.K., et al. Prognostic indicators for blood and marrow transplant patients admitted to an intensive care unit. Am J Respir Crit Care Med 158 3 (1998) 876-884
22. Peters S.G., and Afessa B. Acute lung injury after hematopoietic stem cell transplantation. Clin Chest Med 26 4 (2005) 561-569
23. Afessa B., Tefferi A., Litzow M.R., et al. Outcome of diffuse alveolar hemorrhage in hematopoietic stem cell transplant recipients. Am J Respir Crit Care Med 166 10 (2002) 1364-1368
24. Afessa B., Tefferi A., Litzow M.R., et al. Diffuse alveolar hemorrhage in hematopoietic stem cell transplant recipients. Am J Respir Crit Care Med 166 5 (2002) 641-645
25. Afessa B., and Peters S.G. Major Complications following Hematopoietic Stem Cell Transplantation. Semin Respir Crit Care Med 27 3 (2006) 297-309
26. Pihusch R., Salat C., Schmidt E., et al. Hemostatic complications in bone marrow transplantation: a retrospective analysis of 447 patients. Transplantation 74 9 (2002) 1303-1309
27. Nevo S., Swan V., Enger C., et al. Acute bleeding after bone marrow transplantation (BMT)- incidence and effect on survival. A quantitative analysis in 1,402 patients. Blood 9 14 (1998) 1469-1477
28. Bleggi-Torres L.F., Werner B., Gasparetto E.L., et al. Intracranial hemorrhage following bone marrow transplantation: an autopsy study of 58 patients. Bone Marrow Transplant 29 1 (2002) 29-32
29. Chirletti P., Caronna R., Arcese W., et al. Gastrointestinal emergencies in patients with acute intestinal graft-versus-host disease. Leuk Lymphoma 29 1-2 (1998) 129-137
30. Khassawneh B.Y., White Jr. P., Anaissie E.J., et al. Outcome from mechanical ventilation after autologous peripheral blood stem cell transplantation. Chest 121 1 (2002) 185-188
31. Harvey S., Young D., Brampton W., et al. Pulmonary artery catheters for adult patients in intensive care. Cochrane Database Syst Rev 3 (2006) CD003408
32. Connors Jr. A.F., Speroff T., Dawson N.V., et al. The effectiveness of right heart catheterization in the initial care of critically ill patients. SUPPORT Investigators. JAMA 276 11 (1996) 889-897
33. Feinstein M.B., Mokhtari M., Ferreiro R., et al. Fiberoptic bronchoscopy in allogeneic bone marrow transplantation: findings in the era of serum cytomegalovirus antigen surveillance. Chest 120 4 (2001) 1094-1100
34. Hofmeister C.C., Czerlanis C., Forsythe S., et al. Retrospective utility of bronchoscopy after hematopoietic stem cell transplant. Bone Marrow Transplant 38 10 (2006) 693-698
35. Kasow K.A., King E., Rochester R., et al. Diagnostic yield of bronchoalveolar lavage is low in allogeneic hematopoietic stem cell recipients receiving immunosuppressive therapy or with acute graft-versus-host disease: the St. Jude experience, 1990-2002. Biol Blood Marrow Transplant 13 7 (2007) 831-837
36. Patel N.R., Lee P.S., Kim J.H., et al. The influence of diagnostic bronchoscopy on clinical outcomes comparing adult autologous and allogeneic bone marrow transplant patients. Chest 127 4 (2005) 1388-1396
37. Soubani A.O., Qureshi M.A., and Baynes R.D. Flexible bronchoscopy in the diagnosis of pulmonary infiltrates following autologous peripheral stem cell transplantation for advanced breast cancer. Bone Marrow Transplant 28 10 (2001) 981-985
38. Springmeyer S.C., Silvestri R.C., Sale G.E., et al. The role of transbronchial biopsy for the diagnosis of diffuse pneumonias in immunocompromised marrow transplant recipients. Am Rev Respir Dis 126 5 (1982) 763-765
39. Azoulay E., Mokart D., Rabbat A., et al. Diagnostic bronchoscopy in hematology and oncology patients with acute respiratory failure: prospective multicenter data. Crit Care Med 36 1 (2008) 100-107
40. Bishton M., and Chopra R. The role of granulocyte transfusions in neutropenic patients. Br J Haematol 127 5 (2004) 501-508
41. Hubel K., Carter R.A., Liles W.C., et al. Granulocyte transfusion therapy for infections in candidates and recipients of HPC transplantation: a comparative analysis of feasibility and outcome for community donors versus related donors. Transfusion 42 11 (2002) 1414-1421
42. Stanworth S.J., Massey E., Hyde C., et al. Granulocyte transfusions for treating infections in patients with neutropenia or neutrophil dysfunction. Cochrane Database Syst Rev 3 (2005) CD005339
43. Holler E., Kolb H.J., Greinix H., et al. Bleeding events and mortality in SCT patients: a retrospective study of hematopoietic SCT patients with organ dysfunctions due to severe sepsis or GVHD. Bone Marrow Transplant 43 6 (2009) 491-497
44. Schiffer C.A., Anderson K.C., Bennett C.L., et al. Platelet transfusion for patients with cancer: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 19 5 (2001) 1519-1538
45. Murphy M.F., Wallington T.B., Kelsey P., et al. Guidelines for the clinical use of red cell transfusions. Br J Haematol 113 1 (2001) 24-31
46. Crawford S.W., and Petersen F.B. Long-term survival from respiratory failure after marrow transplantation for malignancy. Am Rev Respir Dis 145 3 (1992) 510-514
47. Epner D.E., White P., Krasnoff M., et al. Outcome of mechanical ventilation for adults with hematologic malignancy. J Investig Med 44 5 (1996) 254-260
48. Faber-Langendoen K., Caplan A.L., and McGlave P.B. Survival of adult bone marrow transplant patients receiving mechanical ventilation: a case for restricted use. Bone Marrow Transplant 12 5 (1993) 501-507
49. Huaringa A.J., Leyva F.J., Giralt S.A., et al. Outcome of bone marrow transplantation patients requiring mechanical ventilation. [see comments]. Crit Care Med 28 4 (2000) 1014-1017
50. Ishida T., Arita M., and Fujimori N. [Diffuse alveolar hemorrhage after allogeneic bone marrow transplantation]. Nihon Kyobu Shikkan Gakkai Zasshi 34 3 (1996) 369-373 [in Japanese]
51. Kress J.P., Christenson J., Pohlman A.S., et al. Outcomes of critically ill cancer patients in a university hospital setting. Am J Respir Crit Care Med 160 6 (1999) 1957-1961
52. Conti G., Marino P., Cogliati A., et al. Noninvasive ventilation for the treatment of acute respiratory failure in patients with hematologic malignancies: a pilot study. Intensive Care Med 24 12 (1998) 1283-1288
53. Hilbert G., Gruson D., Vargas F., et al. Noninvasive ventilation in immunosuppressed patients with pulmonary infiltrates, fever, and acute respiratory failure. N Engl J Med 344 7 (2001) 481-487
54. Azoulay E., Alberti C., Bornstain C., et al. Improved survival in cancer patients requiring mechanical ventilatory support: impact of noninvasive mechanical ventilatory support. Crit Care Med 29 3 (2001) 519-525
55. Van den Berghe G., Wouters P., Weekers F., et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 345 19 (2001) 1359-1367
56. Van den Berghe G., Wilmer A., Hermans G., et al. Intensive insulin therapy in the medical ICU. N Engl J Med 354 5 (2006) 449-461
57. Finfer S., Chittock D.R., Su S.Y., et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med 360 13 (2009) 1283-1297
58. Brunkhorst F.M., Engel C., Bloos F., et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 358 2 (2008) 125-139
59. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med 342 18 (2000) 1301-1308
60. Annane D., Sebille V., Charpentier C., et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 288 7 (2002) 862-871
61. Sprung C.L., Annane D., Keh D., et al. Hydrocortisone therapy for patients with septic shock. N Engl J Med 358 2 (2008) 111-124
62. Bernard G.R., Vincent J.L., Laterre P.F., et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 344 10 (2001) 699-709
63. Eichacker P.Q., Natanson C., and Danner R.L. Surviving sepsis-practice guidelines, marketing campaigns, and Eli Lilly. N Engl J Med 355 16 (2006) 1640-1642
64. Rivers E., Nguyen B., Havstad S., et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345 19 (2001) 1368-1377
65. Ferrer R., Artigas A., Levy M.M., et al. Improvement in process of care and outcome after a multicenter severe sepsis educational program in Spain. JAMA 299 19 (2008) 2294-2303
66. Dellinger R.P., Levy M.M., Carlet J.M., et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 36 1 (2008) 296-327
67. Pastores S.M., Shaw A., Williams M.D., et al. A safety evaluation of drotrecogin alfa (activated) in hematopoietic stem cell transplant patients with severe sepsis: lessons in clinical research. Bone Marrow Transplant 36 8 (2005) 721-724
68. Groeger J.S., Lemeshow S., Price K., et al. Multicenter outcome study of cancer patients admitted to the intensive care unit: a probability of mortality model. J Clin Oncol 16 2 (1998) 761-770
69. Kim S.W., Kami M., Urahama N., et al. Feasibility of acute physiology and chronic health evaluation (APACHE) II and III score-based screening in patients receiving allogeneic hematopoietic stem-cell transplantation. Transplantation 75 4 (2003) 566-570
70. Staudinger T., Stoiser B., Mullner M., et al. Outcome and prognostic factors in critically ill cancer patients admitted to the intensive care unit. Crit Care Med 28 5 (2000) 1322-1328
71. Rubenfeld G.D., and Crawford S.W. Withdrawing life support from mechanically ventilated recipients of bone marrow transplants: a case for evidence-based guidelines. Ann Intern Med 125 8 (1996) 625-633
72. Alasaly K., Muller N., Ostrow D.N., et al. Cryptogenic organizing pneumonia. A report of 25 cases and a review of the literature. Medicine (Baltimore) 74 4 (1995) 201-211
73. Prince D.S., Wingard J.R., Saral R., et al. Longitudinal changes in pulmonary function following bone marrow transplantation. Chest 96 2 (1989) 301-306
74. Ewig S., Torres A., Riquelme R., et al. Pulmonary complications in patients with haematological malignancies treated at a respiratory ICU. Eur Respir J 12 1 (1998) 116-122
75. Afessa B., Gajic O., and Keegan M.T. Severity of illness and organ failure assessment in adult intensive care units. Crit Care Clin 23 3 (2007) 639-658
76. Metnitz P.G., Moreno R.P., Almeida E., et al. SAPS 3-From evaluation of the patient to evaluation of the intensive care unit. Part 1: objectives, methods and cohort description. Intensive Care Med 31 10 (2005) 1336-1344
77. Moreno R.P., Metnitz P.G., Almeida E., et al. SAPS 3-From evaluation of the patient to evaluation of the intensive care unit. Part 2: development of a prognostic model for hospital mortality at ICU admission. Intensive Care Med 31 10 (2005) 1345-1355
78. Zimmerman J.E., Kramer A.A., McNair D.S., et al. Acute Physiology and Chronic Health Evaluation (APACHE) IV: hospital mortality assessment for today's critically ill patients. Crit Care Med 34 5 (2006) 1297-1310
79. Higgins T.L., Teres D., Copes W.S., et al. Assessing contemporary intensive care unit outcome: an updated Mortality Probability Admission Model (MPM0-III). Crit Care Med 35 3 (2007) 827-835
80. Knaus W.A., Draper E.A., Wagner D.P., et al. APACHE II: a severity of disease classification system. Crit Care Med 13 10 (1985) 818-829
81. Knaus W.A., Wagner D.P., Draper E.A., et al. The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults. Chest 100 6 (1991) 1619-1636
82. Le Gall J.R., Lemeshow S., and Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 270 24 (1993) 2957-2963
83. Lemeshow S., Teres D., Klar J., et al. Mortality Probability Models (MPM II) based on an international cohort of intensive care unit patients. JAMA 270 20 (1993) 2478-2486
84. Parimon T., Au D.H., Martin P.J., et al. A risk score for mortality after allogeneic hematopoietic cell transplantation. Ann Intern Med 144 6 (2006) 407-414
85. Thiery G., Azoulay E., Darmon M., et al. Outcome of cancer patients considered for intensive care unit admission: a hospital-wide prospective study. J Clin Oncol 23 19 (2005) 4406-4413
86. Lecuyer L., Chevret S., Thiery G., et al. The ICU trial: a new admission policy for cancer patients requiring mechanical ventilation. Crit Care Med 35 3 (2007) 808-814
87. Azoulay E., and Afessa B. The intensive care support of patients with malignancy: do everything that can be done. Intensive Care Med 32 1 (2006) 3-5